Guardant Well being, Inc. (NASDAQ:GH) to Publish FY2022 Earnings of ($6.59) Per Share, SVB Leerink Forecasts

0
3


Guardant Well being, Inc. (NASDAQ:GHGet Score) – Analysts at SVB Leerink dropped their FY2022 EPS estimates for shares of Guardant Well being in a report launched on Thursday, January twelfth. SVB Leerink analyst P. Souda now expects that the corporate will publish earnings of ($6.59) per share for the yr, down from their prior estimate of ($6.57). The consensus estimate for Guardant Well being’s present full-year earnings is ($6.46) per share. SVB Leerink additionally issued estimates for Guardant Well being’s This fall 2022 earnings at ($1.55) EPS, Q1 2023 earnings at ($1.39) EPS, Q2 2023 earnings at ($1.31) EPS, FY2023 earnings at ($5.20) EPS and FY2024 earnings at ($4.84) EPS.

Guardant Well being (NASDAQ:GHGet Score) final introduced its earnings outcomes on Thursday, November third. The corporate reported ($1.58) EPS for the quarter, lacking the consensus estimate of ($1.27) by ($0.31). Guardant Well being had a detrimental return on fairness of 145.58% and a detrimental internet margin of 140.58%. The agency had income of $117.40 million for the quarter, in comparison with the consensus estimate of $118.18 million.

A number of different equities analysts have additionally weighed in on GH. Cowen lowered their value goal on shares of Guardant Well being from $110.00 to $83.00 in a analysis report on Friday, November 4th. BTIG Analysis decreased their value goal on shares of Guardant Well being from $80.00 to $60.00 in a analysis report on Friday, December sixteenth. JPMorgan Chase & Co. minimize their value goal on Guardant Well being from $100.00 to $85.00 and set an “chubby” score for the corporate in a analysis report on Friday, November 18th. Stephens decreased their goal value on Guardant Well being from $99.00 to $90.00 and set an “chubby” score on the inventory in a report on Monday, November seventh. Lastly, Cowen lowered their goal value on Guardant Well being from $83.00 to $70.00 in a report on Friday, December sixteenth. One analyst has rated the inventory with a maintain score and fifteen have issued a purchase score to the corporate’s inventory. Based mostly on information from MarketBeat, the corporate has a mean score of “Reasonable Purchase” and a consensus value goal of $90.39.

Guardant Well being Buying and selling Down 0.8 %

Shares of GH inventory opened at $30.43 on Monday. The inventory has a 50-day easy shifting common of $39.99 and a 200 day easy shifting common of $46.95. The inventory has a market capitalization of $3.12 billion, a P/E ratio of -5.13 and a beta of 0.83. Guardant Well being has a fifty-two week low of $24.63 and a fifty-two week excessive of $79.24. The corporate has a fast ratio of 6.10, a present ratio of 6.46 and a debt-to-equity ratio of 6.82.

Insider Shopping for and Promoting

In different Guardant Well being information, insider Kumud Kalia offered 3,125 shares of the corporate’s inventory in a transaction that occurred on Tuesday, November fifteenth. The shares have been offered at a mean value of $51.87, for a complete worth of $162,093.75. Following the transaction, the insider now owns 20,135 shares within the firm, valued at roughly $1,044,402.45. The transaction was disclosed in a doc filed with the SEC, which could be accessed via this hyperlink. 5.90% of the inventory is at the moment owned by company insiders.

Institutional Inflows and Outflows

Numerous institutional buyers and hedge funds have just lately purchased and offered shares of GH. Xponance Inc. grew its place in Guardant Well being by 2.4% within the third quarter. Xponance Inc. now owns 11,639 shares of the corporate’s inventory value $627,000 after buying an extra 269 shares within the final quarter. Captrust Monetary Advisors raised its holdings in Guardant Well being by 33.2% in the course of the second quarter. Captrust Monetary Advisors now owns 1,087 shares of the corporate’s inventory valued at $44,000 after shopping for an extra 271 shares within the final quarter. Commonwealth Fairness Companies LLC lifted its place in shares of Guardant Well being by 4.9% within the second quarter. Commonwealth Fairness Companies LLC now owns 6,120 shares of the corporate’s inventory value $246,000 after shopping for an extra 286 shares over the last quarter. Manchester Capital Administration LLC boosted its stake in shares of Guardant Well being by 43.0% in the course of the third quarter. Manchester Capital Administration LLC now owns 965 shares of the corporate’s inventory value $52,000 after buying an extra 290 shares within the final quarter. Lastly, Baird Monetary Group Inc. elevated its holdings in shares of Guardant Well being by 2.1% in the course of the third quarter. Baird Monetary Group Inc. now owns 14,580 shares of the corporate’s inventory valued at $785,000 after buying an extra 296 shares over the last quarter. Hedge funds and different institutional buyers personal 90.43% of the corporate’s inventory.

Guardant Well being Firm Profile

(Get Score)

Guardant Well being, Inc, a precision oncology firm, gives blood checks, information units, and analytics in america and internationally. The corporate provides Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based checks for superior stage most cancers; and GuardantINFORM, an in-silico analysis platform that comprise a clinical-genomic liquid biopsy dataset of superior most cancers sufferers.

See Additionally

This instantaneous information alert was generated by narrative science expertise and monetary information from MarketBeat in an effort to present readers with the quickest and most correct reporting. This story was reviewed by MarketBeat’s editorial workforce previous to publication. Please ship any questions or feedback about this story to contact@marketbeat.com.

Earlier than you think about Guardant Well being, you may wish to hear this.

MarketBeat retains monitor of Wall Avenue’s top-rated and finest performing analysis analysts and the shares they advocate to their purchasers each day. MarketBeat has recognized the 5 shares that prime analysts are quietly whispering to their purchasers to purchase now earlier than the broader market catches on… and Guardant Well being wasn’t on the checklist.

Whereas Guardant Well being at the moment has a “Reasonable Purchase” score amongst analysts, top-rated analysts consider these 5 shares are higher buys.

View The 5 Shares Right here

20 Shares to Promote Now

MarketBeat has simply launched its checklist of 20 shares that Wall Avenue analysts hate. These corporations could seem to have good fundamentals, however prime analysts scent one thing critically rotten. Are any of those corporations lurking round your portfolio? Discover out by getting into your e mail handle beneath.

Get This Free Report

20 Stocks to Sell Now Cover



Supply hyperlink

LEAVE A REPLY

Please enter your comment!
Please enter your name here